| Nazwa produktu: |
2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one |
| Angielska nazwa |
2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one; (1S,3R,4S)-2-amino-9-[4-(benzyloxy)-3-(benzyloxymethyl)-2-methylidene-cyclopentyl]-3H-purin-6-one; Entecavir intermediate N8; 10-Oxy Iminostilbene Carbonyl Chloride; Entecavir intermediate N-1
; 2-amino-9-{(1S,3R,4S)-4-(benzyloxy)-3-[(benzyloxy)methyl]-2-methylidenecyclopentyl}-1,9-dihydro-6H-purin-6-one; 2-amino-9-((1S,3R,4S)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylenecyclopentyl)-9H-purin-6-ol; The intermediate of Entecavir hydrate; (1S,3R,4S)-2-amino-9-[4-(benzyloxy)-3-(benzyloxymethyl)- 2-methylidene-cyclopentyl]-6H-purin-6-one; 2-amino-9-((1S,3R,4S)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylenecyclophentyl)-1H-purin-6(9H)-one; Entecavir intermediate 8; Intermediate of Entecavir 4; 6H-Purin-6-one, 2-amino-1,9-dihydro-9-[(1S,3R,4S)-2-methylene-4-(phenylmethoxy)-3-[(phenylmethoxy)methyl]cyclopentyl]-; 2-amino-9-((1S,3R,4S)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylenecyclopentyl)-1H-purin-6(9H)-one; 2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one(E8); Entecavir E8 |
| MF |
C26H27N5O3 |
| Masie cząsteczkowej |
457.5243 |
| InChI |
InChI=1/C26H27N5O3/c1-17-20(15-33-13-18-8-4-2-5-9-18)22(34-14-19-10-6-3-7-11-19)12-21(17)31-16-28-23-24(31)29-26(27)30-25(23)32/h2-11,16,20-22H,1,12-15H2,(H3,27,29,30,32)/t20-,21-,22-/m0/s1 |
| Nr CAS |
142217-81-0 |
| Struktury molekularnej |
![142217-81-0 2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one](https://images-a.chemnet.com/suppliers/chembase/cas/cas142217-81-0.gif)
|
| Gęstość |
1.34g/cm3 |
| Współczynnik załamania |
1.679 |
| Symbole zagrożenia |
|
| Kody ryzyka |
|
| Bezpieczeństwo opis |
|
|
